Trial Profile
A Phase I clinical trial to assess safety and immune response of Trivalent, Live Attenuated Seasonal Influenza vaccine of SIIL in Adults.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Influenza vaccine live attenuated (Nasovac-S) (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 27 Mar 2012 New trial record